Welcome to LookChem.com Sign In|Join Free

CAS

  • or

121250-06-4

Post Buying Request

121250-06-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

121250-06-4 Usage

Uses

Different sources of media describe the Uses of 121250-06-4 differently. You can refer to the following data:
1. 14-Chloro Daunorubicin belongs to adriamycin analogue,it is used as an anticancer agent.
2. Adriamycin analogue; use as anticancer agent.

Check Digit Verification of cas no

The CAS Registry Mumber 121250-06-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,1,2,5 and 0 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 121250-06:
(8*1)+(7*2)+(6*1)+(5*2)+(4*5)+(3*0)+(2*0)+(1*6)=64
64 % 10 = 4
So 121250-06-4 is a valid CAS Registry Number.
InChI:InChI=1/C27H28ClNO10/c1-10-22(31)13(29)6-17(38-10)39-15-8-27(36,16(30)9-28)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,31,33,35-36H,6-9,29H2,1-2H3

121250-06-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 14-Chloro Daunorubicin

1.2 Other means of identification

Product number -
Other names 14-chlorodaunorubicin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:121250-06-4 SDS

121250-06-4Upstream product

121250-06-4Downstream Products

121250-06-4Relevant articles and documents

PRODRUGS ACTIVATED BY CASPASE

-

Paragraph 0120, (2016/06/13)

Described are prodrug conjugates that release a chemotherapeutic agent upon activation by caspase, and methods using such prodrug conjugates to induce apoptosis, amplify apoptosis, and treat cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 121250-06-4